Stocktoria
Akzo Nobel N.V. AKZA.AS
NL · Euronext Amsterdam · XAMS · stock · Basic Materials · website
Akzo Nobel N.V. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €10.2B | €10.7B | €10.7B | €10.8B |
| Gross profit | €4.0B | €4.3B | €4.2B | €3.9B |
| R&D expense | €274.0M | €296.0M | €270.0M | €258.0M |
| SG&A expense | €1.5B | €1.6B | €1.5B | €1.5B |
| Operating income | €1.2B | €917.0M | €1.0B | €708.0M |
| Interest expense | €211.0M | €190.0M | €193.0M | €106.0M |
| Income tax | €326.0M | €246.0M | €296.0M | €214.0M |
| Net income | €635.0M | €542.0M | €442.0M | €352.0M |
| EPS (diluted) | €3.69 | €3.16 | €2.58 | €2.01 |
| Operating cash flow | €915.0M | €673.0M | €1.1B | €263.0M |
| Free cash flow | €606.0M | €367.0M | €840.0M | -€29.0M |
| Cash & equivalents | €1.6B | €1.3B | €1.5B | €1.4B |
| Inventory | €1.5B | €1.7B | €1.6B | €1.8B |
| Goodwill | €1.4B | €1.4B | €1.4B | €1.4B |
| Total assets | €14.0B | €14.2B | €14.6B | €14.7B |
| Total debt | €4.9B | €5.4B | €5.6B | €5.9B |
| Total liabilities | €9.1B | €9.4B | €10.0B | €10.2B |
| Shareholders' equity | €4.7B | €4.6B | €4.3B | €4.3B |
| Share buybacks | — | €0 | €0 | €669.0M |
Growth · year-over-year · Revenue CAGR -2.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -5.2% | +0.4% | -1.6% | — |
| Net income growth | +17.2% | +22.6% | +25.6% | — |
| EPS growth | +16.8% | +22.5% | +28.4% | — |
| Free cash flow growth | +65.1% | -56.3% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · NL · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.